Found: 17
Select item for more details and to access through your institution.
Pazopanib with 5‐FU and oxaliplatin as first line therapy in advanced gastric cancer: A randomized phase‐II study—The PaFLO trial. A study of the Arbeitsgemeinschaft Internistische Onkologie AIO‐STO‐0510.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 6, p. 1007, doi. 10.1002/ijc.33864
- By:
- Publication type:
- Article
Comprehensive clinicopathologic study of alpha fetoprotein‐expression in a large cohort of patients with hepatocellular carcinoma.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 6, p. 1053, doi. 10.1002/ijc.33898
- By:
- Publication type:
- Article
Hepatitis B virus infection and the risk of gastrointestinal cancers among Chinese population: A prospective cohort study.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 6, p. 1018, doi. 10.1002/ijc.33891
- By:
- Publication type:
- Article
The clinical utility and safety of short‐course immune checkpoint inhibitors in multiple tumours—A real‐world multicentric study from India.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 6, p. 1045, doi. 10.1002/ijc.33868
- By:
- Publication type:
- Article
Genetically determined cutaneous nevi and risk of cancer.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 6, p. 961, doi. 10.1002/ijc.33874
- By:
- Publication type:
- Article
Citrus‐Gene interaction and melanoma risk in the UK Biobank.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 6, p. 976, doi. 10.1002/ijc.33862
- By:
- Publication type:
- Article
Safety, pharmacokinetic, pharmacodynamic and clinical activity of molibresib for the treatment of nuclear protein of the testis carcinoma and other cancers: Results of a Phase I/II open‐label, dose escalation study.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 6, p. 993, doi. 10.1002/ijc.33861
- By:
- Publication type:
- Article
A disease network‐based deep learning approach for characterizing melanoma.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 6, p. 1029, doi. 10.1002/ijc.33860
- By:
- Publication type:
- Article
Accuracy of different triage strategies for human papillomavirus positivity in an Italian screening population.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 6, p. 952, doi. 10.1002/ijc.33858
- By:
- Publication type:
- Article
Social inequalities in treatment receipt for childhood cancers in Ireland: A population‐based analysis.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 6, p. 941, doi. 10.1002/ijc.33856
- By:
- Publication type:
- Article
Camrelizumab for relapsed or refractory classical Hodgkin lymphoma: Extended follow‐up of the multicenter, single‐arm, Phase 2 study.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 6, p. 984, doi. 10.1002/ijc.33852
- By:
- Publication type:
- Article
Oral and gastric microbiome in relation to gastric intestinal metaplasia.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 6, p. 928, doi. 10.1002/ijc.33848
- By:
- Publication type:
- Article
Prospective study of oral microbiome and gastric cancer risk among Asian, African American and European American populations.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 6, p. 916, doi. 10.1002/ijc.33847
- By:
- Publication type:
- Article
Low‐dose aspirin use and mortality risk in patients with head and neck cancer: A nationwide cohort study of 10 770 patients.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 6, p. 969, doi. 10.1002/ijc.33814
- By:
- Publication type:
- Article
Neuroblastoma—Telomere maintenance, deregulated signaling transduction and beyond.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 6, p. 903, doi. 10.1002/ijc.33839
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 6, p. 897, doi. 10.1002/ijc.33634
- Publication type:
- Article
Issue Information.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 6, p. 1067, doi. 10.1002/ijc.33633
- Publication type:
- Article